Skip to content

EndoChoice Holdings, Inc.

Delisted

CIK 1623919fmd_1TR9W6SD6YSH38XJAVCC9ZACSVManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2013 to Sep 30, 2016, 13 periods

Income Statement · Annual · Millions · USD
Line itemFY2013FY2014FY2015
Total revenues516172
Cost of revenue263949
Gross profit252323
Research and development172217
Selling, general and administrative304454
Total operating expenses517074
Operating income(26)(47)(50)
Interest expense045
Other non-operating income (expense)0(6)(9)
Income before taxes(25)(53)(60)
Income tax expense(2)1(0)
Net income from continuing operations(24)(54)(59)
Net income(24)(54)(59)
EndoChoice Holdings, Inc. financial statements · FinancialMD